None listed
Conditions
Interventions
Drug : Children in the Midazolam group recieved an initial dose of 0.4mg/kg midazolam (Bukwang Midazolam Inj. 15mg/3mL) using 1cc syrynge connected to an intranasal mucosal atomization device. midazol
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children aged 1 to 5 who visited the pediatric emergency department requiring noncontrast computed tomography under procedural sedation.
Exclusion criteria
Exclusion criteria: - Children whose American Society of Anesthesiologists physical status classification (ASA) is 3, 4, 5 - Children with suspected otolaryngeal disease or trauma - Children weighing 20kg or more - Children with history of previous side effects of sedatives and for whom any of the sedatives were contraindicated. - Children whose vital signs are unstable or requiring urgent intervention. - Child's caregiver have insufficient knowlege of Korean to understand the study protocol. - Intravenous line has already been placed or is planned for a purpose other than procedural sedation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| success rates of sedation | — |
Secondary
| Measure | Time frame |
|---|---|
| Total sedation time ;Induction time;Time to return to baseline ;Sedation depth ;Number of sedatives administered;Dose of sedatives administered ;Adverse events;caregiver satisfaction with sedation | — |
Countries
Korea, Republic of
Contacts
Public ContactHa Ni Lee
Seoul National University Hospital
Outcome results
None listed